Reduced conduction reserve in the diabetic rat heart: Role of iPLA 2 activation in the response to ischemia

American Journal of Physiology - Heart and Circulatory Physiology

Volumn 300, Issue 1, 2011, Pages

  Rahnema, Parisa ^a   Shimoni, Yakhin ^a   Nygren, Anders ^a  

^a UNIVERSITY OF CALGARY   (Canada)

Author keywords

Arrhythmia; Calcium independent phospholipase A2; Conduction velocity; Connexins; Diabetes; Phospholipase A2

Indexed keywords

BROMOENOL LACTONE; CALCIUM INDEPENDENT PHOSPHOLIPASE A2;

ACIDOSIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; ELECTRIC POTENTIAL; FEMALE; HEART ARRHYTHMIA; HEART MUSCLE ISCHEMIA; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; STREPTOZOCIN DIABETES; VOLTAGE SENSITIVE DYE IMAGING;

ANALYSIS OF VARIANCE; ANIMALS; ARRHYTHMIAS, CARDIAC; DIABETES MELLITUS, EXPERIMENTAL; FEMALE; HEART; HEART CONDUCTION SYSTEM; MALE; MYOCARDIAL ISCHEMIA; MYOCARDIUM; PHOSPHOLIPASES A2, CALCIUM-INDEPENDENT; RATS; RATS, SPRAGUE-DAWLEY;

EID: 78651306995     PISSN: 03636135     EISSN: 15221539     Source Type: Journal    
DOI: 10.1152/ajpheart.00743.2010     Document Type: Article

References (55)

1. Abo K, Ishida Y, Yoshida R, Hozumi T, Ueno H, Shiotani H, Matsunaga K, Kazumi T. Torsade de pointes in NIDDM with long QT intervals. Diabetes Care 19: 1010, 1996.
2. Arnsdorf MF, Sawicki GJ. The effects of lysophosphatidylcholine, a toxic metabolite of ischemia, on the components of cardiac excitability in sheep Purkinje fibers. Circ Res 49: 16-30, 1981.
3. Boger DL, Sato H, Lerner AE, Guan X, Gilula NB. Arachidonic acid amide inhibitors of gap junction cell-cell communication. Bioorg Med Chem Lett 9: 1151-1154, 1999.
4. Carmeliet E. Cardiac ionic currents and acute ischemia: from channels to arrhythmias. Physiol Rev 79: 917-1017, 1999.
5. Cedars A, Jenkins CM, Mancuso DJ, Gross RW. Calcium-independent phospholipases in the heart: mediators of cellular signaling, bioenergetics, and ischemia-induced electrophysiologic dysfunction. J Cardiovasc Pharmacol 53: 277-289, 2009.
6. Christensen PK, Gall MA, Major-Pedersen A, Sato A, Rossing P, Breum L, Pietersen A, Kastrup J, Parving HH. QTc interval length and QT dispersion as predictors of mortality in patients with noninsulin-dependent diabetes. Scand J Clin Lab Invest 60: 323-332, 2000.
7. Corr PB, Saffitz JE, Sobel BE. Lysophospholipids, long chain acylcarnitines and membrane dysfunction in the ischaemic heart. Basic Res Cardiol 82, Suppl 1: 199-208, 1987.
8. Corr PB, Yamada KA, Creer MH, Sharma AD, Sobel BE. Lysophosphoglycerides and ventricular fibrillation early after onset of ischemia. J Mol Cell Cardiol 19, Suppl 5: 45-53, 1987.
9. Daleau P. Lysophosphatidylcholine, a metabolite which accumulates early in myocardium during ischemia, reduces gap junctional coupling in cardiac cells. J Mol Cell Cardiol 31: 1391-1401, 1999.
10. Danaei G, Lawes CM, Vander HS, Murray CJ, Ezzati M. Global and regional mortality from ischaemic heart disease and stroke attributable to higher-than-optimum blood glucose concentration: comparative risk assessment. Lancet 368: 1651-1659, 2006.
11. de Groot JR, Coronel R. Acute ischemia-induced gap junctional uncoupling and arrhythmogenesis. Cardiovasc Res 62: 323-334, 2004.
12. De Mello WC. Impaired cell communication in the diabetic heart. The role of the renin angiotensin system. Mol Cell Biochem 296: 53-58, 2007.
13. El-Atat FA, McFarlane SI, Sowers JR, Bigger JT. Sudden cardiac death in patients with diabetes. Curr Diab Rep 4: 187-193, 2004.
14. Fang ZY, Prins JB, Marwick TH. Diabetic cardiomyopathy: evidence, mechanisms, and therapeutic implications. Endocr Rev 25: 543-567, 2004.
15. Fluri GS, Rudisuli A, Willi M, Rohr S, Weingart R. Effects of arachidonic acid on the gap junctions of neonatal rat heart cells. Pflügers Arch 417: 149-156, 1990.
16. Fonarow GC. An approach to heart failure and diabetes mellitus. Am J Cardiol 96: 47E-52E, 2005.
17. Ghaly H, Boyle P, Vigmond E, Nygren A. Reduced conduction reserve of the propagating cardiac impulse in the diabetic rat heart: a model study. Conf Proc IEEE Eng Med Biol Soc: 5926-5929, 2008.
18. Ghaly HA, Boyle PM, Vigmond EJ, Shimoni Y, Nygren A. Simulations of reduced conduction reserve in the diabetic rat heart: response to uncoupling and reduced excitability. Ann Biomed Eng 38: 1415-1425, 2010.
19. 2. J Biol Chem 270: 2885-2888, 1995.
20. Hashizume H, Hoque AN, Magishi K, Hara A, Abiko Y. A new approach to the development of anti-ischemic drugs. Substances that counteract the deleterious effect of lysophosphatidylcholine on the heart. Jpn Heart J 38: 11-25, 1997.
21. Jenkins CM, Cedars A, Gross RW. Eicosanoid signalling pathways in the heart. Cardiovasc Res 82: 240-249, 2009.
22. 2+ current via activation of protein kinase C in rabbit portal vein smooth muscle cells. Kor J Physiol Pharmacol 12: 31-35, 2008.
23. Lazrak A, Peres A, Giovannardi S, Peracchia C. Ca-mediated and independent effects of arachidonic acid on gap junctions and Ca-independent effects of oleic acid and halothane. Biophys J 67: 1052-1059, 1994.
24. Lerner DL, Yamada KA, Schuessler RB, Saffitz JE. Accelerated onset and increased incidence of ventricular arrhythmias induced by ischemia in Cx43-deficient mice. Circulation 101: 547-552, 2000.
25. Lin H, Ogawa K, Imanaga I, Tribulova N. Remodeling of connexin 43 in the diabetic rat heart. Mol Cell Biochem 290: 69-78, 2006. (Pubitemid 44473236)
26. 2+ cycling by lysoplasmenylcholine in adult rabbit ventricular myocytes. Am J Physiol Cell Physiol 284: C826-C838, 2003.
27. London B. Cardiac arrhythmias: from (transgenic) mice to men. J Cardiovasc Electrophysiol 12: 1089-1091, 2001.
28. Man RY. Lysophosphatidylcholine-induced arrhythmias and its accumulation in the rat perfused heart. Br J Pharmacol 93: 412-416, 1988.
29. 2β, precipitating ventricular tachyarrhythmias in transgenic mice: rescue of the lethal electrophysiologic phenotype by mechanism-based inhibition. J Biol Chem 278: 22231-22236, 2003.
30. Massey KD, Minnich BN, Burt JM. Arachidonic acid and lipoxygenase metabolites uncouple neonatal rat cardiac myocyte pairs. Am J Physiol Cell Physiol 263: C494-C501, 1992.
31. 2 in ventricular myocytes. Am J Physiol Cell Physiol 274: C447-C454, 1998.
32. 2 and conservation of plasmalogen polyunsaturated fatty acids in diabetic heart. Am J Physiol Endocrinol Metab 279: E25-E32, 2000.
33. 2 in hypoxic ventricular myocytes. Am J Physiol Cell Physiol 274: C1727-C1737, 1998.
34. McHowat J, Yamada KA, Wu J, Yan GX, Corr PB. Recent insights pertaining to sarcolemmal phospholipid alterations underlying arrhythmogenesis in the ischemic heart. J Cardiovasc Electrophysiol 4: 288-310, 1993.
35. Mooradian AD. Cardiovascular disease in type 2 diabetes mellitus: current management guidelines. Arch Intern Med 163: 33-40, 2003.
36. Nygren A, Baczko I, Giles WR. Measurements of electrophysiological effects of components of acute ischemia in Langendorff-perfused rat hearts using voltage-sensitive dye mapping. J Cardiovasc Electrophysiol 17, Suppl 1: S113-S123, 2006.
37. Nygren A, Clark RB, Belke DD, Kondo C, Giles WR, Witkowski FX. Voltage-sensitive dye mapping of activation and conduction in adult mouse hearts. Ann Biomed Eng 28: 958-967, 2000. (Pubitemid 32085382)
38. +] in a human atrial strand. Ann Biomed Eng 28: 951-957, 2000.
39. Nygren A, Kondo C, Clark RB, Giles WR. Voltage-sensitive dye mapping in Langendorff-perfused rat hearts. Am J Physiol Heart Circ Physiol 284: H892-H902, 2003.
40. Nygren A, Olson ML, Chen KY, Emmett T, Kargacin G, Shimoni Y. Propagation of the cardiac impulse in the diabetic rat heart: reduced conduction reserve. J Physiol 580: 543-560, 2007.
41. Otel I, Ledru F, Danchin N. Ischemic heart disease in type 2 diabetes. Metabolism 52: 6-12, 2003.
42. Rossing P, Breum L, Major-Pedersen A, Sato A, Winding H, Pietersen A, Kastrup J, Parving HH. Prolonged QTc interval predicts mortality in patients with type 1 diabetes mellitus. Diabet Med 18: 199-205, 2001.
43. 2 inhibition in ischemic rat hearts. Cardiovasc Res 31: 270-277, 1996.
44. Schmilinsky-Fluri G, Valiunas V, Willi M, Weingart R. Modulation of cardiac gap junctions: the mode of action of arachidonic acid. J Mol Cell Cardiol 29: 1703-1713, 1997.
45. Shimoni Y, Emmett T, Schmidt R, Nygren A, Kargacin G. Sex-dependent impairment of cardiac action potential conduction in type 1 diabetic rats. Am J Physiol Heart Circ Physiol 296: H1442-H1450, 2009.
46. + currents in rat ventricular myocytes. Circ Res 74: 620-628, 1994.
47. Smeets JLRM, Allessie MA, Lammers WJEP, Bonke FIM, Hollen J. The wavelength of the cardiac impulse and reentrant arrhythmias in isolated rabbit atrium: the role of heart rate, autonomic transmitters, temperature, and potassium. Circ Res 58: 96-108, 1986.
48. Su X, Han X, Mancuso DJ, Abendschein DR, Gross RW. Accumulation of long-chain acylcarnitine and 3-hydroxy acylcarnitine molecular species in diabetic myocardium: identification of alterations in mitochondrial fatty acid processing in diabetic myocardium by shotgun lipidomics. Biochemistry 44: 5234-5245, 2005.
49. Tappia PS. Phospholipid-mediated signaling systems as novel targets for treatment of heart disease. Can J Physiol Pharmacol 85: 25-41, 2007.
50. Valiunas V, Bukauskas FF, Weingart R. Conductances and selective permeability of connexin43 gap junction channels examined in neonatal rat heart cells. Circ Res 80: 708-719, 1997.
51. van Rijen HV, de Bakker JM, van Veen TA. Hypoxia, electrical uncoupling, and conduction slowing: role of conduction reserve. Cardiovasc Res 66: 9-11, 2005.
52. Weingart R, Bukauskas FF. Long-chain n-alkanols and arachidonic acid interfere with the Vm-sensitive gating mechanism of gap junction channels. Pflügers Arch 435: 310-319, 1998.
53. 2. Implications for cardiac cycle-dependent alterations in phospholipolysis. J Biol Chem 271: 20989-20992, 1996.
54. + current in rabbit coronary smooth muscle cells. J Vet Med Sci 63: 395-399, 2001.
55. Zimmet P, Alberti KG, Shaw J. Global and societal implications of the diabetes epidemic. Nature 414: 782-787, 2001.